Company Filing History:
Years Active: 2018
Title: Innovations in Pharmaceutical Compositions: The Work of Katrin Tertsch
Introduction: Katrin Tertsch, based in Frankfurt am Main, Germany, is a notable inventor recognized for her contributions to the field of pharmaceuticals. She holds a patent that focuses on a unique composition aimed at enhancing therapeutic outcomes for patients.
Latest Patents: Katrin's patent involves a pharmaceutical composition comprising a GLP-1 agonist, insulin, and methionine. This innovative liquid composition is designed as an add-on therapy with metformin where appropriate. The formulation comprises a GLP-1 agonist or a pharmacologically tolerable salt thereof, insulin or a pharmacologically tolerable salt thereof, and optionally includes at least one pharmaceutically acceptable excipient. The inclusion of methionine in the composition sets it apart, potentially offering improved treatment options for patients managing diabetes.
Career Highlights: Katrin Tertsch is associated with Sanofi-a Ventis Deutschland GmbH, a leading company in the pharmaceutical industry. Her role there has allowed her to explore and develop innovative solutions that address critical health challenges. The patent she holds stands as a testament to her dedication and expertise in advancing effective medication.
Collaborations: Throughout her career, Katrin has collaborated with talented coworkers, including Annika Hagendorf and Gerrit Hauck. Working alongside such skilled professionals has enabled her to refine her ideas and strengthen the development of her innovative compositions.
Conclusion: Katrin Tertsch's work in pharmaceutical innovation highlights the importance of research and development in healthcare. Her patent not only showcases her inventive spirit but also has the potential to positively impact patient care. As advancements in pharmaceuticals continue to evolve, inventors like Katrin play a crucial role in shaping the future of medicine.